CliffBio
small molecule

ZURNAI (AUTOINJECTOR)

NALMEFENE HYDROCHLORIDE

Loss of exclusivityNovember 2039latest FDA-listed patent expiry
CompanyKNOA →See this company's full patent-cliff portfolio

Drug detail

Brand nameZURNAI (AUTOINJECTOR)
Active ingredientNALMEFENE HYDROCHLORIDE
StrengthEQ 1.5MG BASE/0.5ML (EQ 1.5MG BASE/0.5ML)
Dosage formSOLUTION
RouteINTRAMUSCULAR, SUBCUTANEOUS
ModalitySmall molecule
FDA approvalAugust 2024
Marketing statusRX

Listed patents

PatentExpiresType
11865112November 2039product
11857547November 2039product

Regulatory exclusivity

CodeExpires
NPAugust 2027

More from KNOA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.